EDIT 2.44 (+2.95%)
US28106W1036BiotechnologyBiotechnology

Editas Medicine (EDIT) Financial Metrics

This table shows a selected set of financial data points of Editas Medicine (EDIT). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -2.02 0 -5.02 769.53M -0.3 78.12M -136.9M -163.12M -153.22M 123.65M
2022 -3.21 0 -2.76 609.06M -0.37 19.71M -181.47M -219.61M -220.43M 141.52M
2021 -2.85 0 -9.33 1.8B -0.31 25.54M -171.78M -188.09M -192.5M 203.52M
2020 -1.98 0 -35.43 4.11B -0.21 90.73M -187.01M -130.88M -115.98M 139.68M
2019 -2.68 0 -11.07 1.48B -0.29 20.53M -46.84M -141.06M -133.75M 238.18M
2018 -2.33 0 -9.74 1.07B -0.28 31.94M -50.46M -110.15M -109.95M 134.78M
2017 -2.98 0 -10.3 1.24B -0.4 13.73M -11.48M -116.66M -120.32M 146.63M
2016 -3.02 0 -5.38 522.93M -0.51 6.05M -53.42M -96.09M -97.23M 185.32M
2015 -2.05 0 0 0 -0.91 1.63M -6.83M -72.68M -73.29M 143.18M
2014 -3.47 0 0 0 -1.91 0 -9.87M -13.8M -13.99M 10.62M
2013 0 0 0 0 0 0 0 0 0 2.01M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.